Clinical Trials Logo
  1. Home
  2. Atopic Asthma
  3. NCT02758548

Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects

Atopic Asthma Clinical Trial

Official title:
A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement Using a Novel Point of Care Test Device Compared to a Reference Method in Atopic Subjects

Clinical Trial Summary

The purpose of this study is to determine the accuracy of the Novel point of care test (POCT) total IgE assay in atopic patients.

120 patients with atopic conditions and approximately 40 healthy subjects will be enrolled. Fingerstick capillary blood samples will be collected and tested in the POCT device. Venous samples will be collected and sent to a reference laboratory for measurement of serum total IgE using the reference immunoassay method.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02758548
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date March 2016
Completion date May 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01448954 - A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma Phase 2
Withdrawn NCT01049178 - Randomized Controlled Trial of Silymarin in Asthma Phase 2/Phase 3
Terminated NCT00644514 - Genetics of Asthma - Bronchoscopy Studies Phase 1
Completed NCT00861211 - Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects Phase 2
Completed NCT00784459 - The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics Phase 2
Terminated NCT00671593 - Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge Phase 1
Completed NCT05098600 - The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
Completed NCT01420003 - Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics N/A
Completed NCT01179256 - Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma N/A
Completed NCT01545245 - Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants N/A
Completed NCT03603522 - Probiotics and Capsaicin Evoked Coughs N/A
Completed NCT04728711 - A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) Phase 2
Recruiting NCT03928431 - Restoration of Microbiota in Neonates N/A
Completed NCT02327234 - Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma N/A
Completed NCT01890161 - A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma Phase 2
Completed NCT03665701 - Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites N/A
Completed NCT04397081 - Atopic Diseases & Human Papilloma Virus